Sachi Bioworks, Inc. — Federal Contractor Profile
SACHI BIOWORKS, INC. Secures $22.4M in Federal Contracts, No Recent Wins
Contractor Overview
Total Contract Value: $22,445,714 ($22.4M)
Total Awards: 7
Company Profile
SACHI BIOWORKS, INC. is a federal contractor with a total government contract value of $22.4 million, spanning 7 contracts averaging $3.2 million each. The company has not won any new contracts recently, indicating a potential slowdown in new business. SACHI BIOWORKS, INC. does not have any sole-source contracts, suggesting a focus on competitive bidding. However, the lack of recent contracts and the absence of specific agency clients make it challenging to assess their current role and dependency patterns. The company's core capabilities and specializations are not clearly defined from the available data, but their focus on biotechnology and related services is implied by their contract descriptions. SACHI BIOWORKS, INC. appears to be a niche player in the biotechnology sector, with a limited but significant presence in federal contracting. Their contract patterns suggest a stable but potentially declining business strategy, as they have not secured new contracts in recent years. Comparatively, SACHI BIOWORKS, INC. may face challenges in maintaining its market position without a robust pipeline of new contracts.
Specializations
- Biotechnology
- Biological Research
- Laboratory Services
- Biological Testing
- Contract Research Organization (CRO) Services
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 100%
Agency Concentration: N/A
Growth Trajectory: Stable
Sole Source Rate: 0%
Recompete Rate: N/A
Competitive Position
SACHI BIOWORKS, INC. appears to be a niche player in the biotechnology sector, focusing on specialized services such as biological research and laboratory testing. Their lack of sole-source contracts and absence of recent wins suggest they are competing effectively but may face challenges in securing new business. Their focus on competitive bidding indicates a strong emphasis on fair competition and transparency in the contracting process.
Value to Taxpayers
SACHI BIOWORKS, INC. provides specialized biotechnology services, which are essential for federal research and development. Their competitive bidding approach suggests they are offering fair and transparent services. However, the absence of recent contracts and the lack of specific agency clients make it difficult to assess their overall value to taxpayers. Their contract sizes are in line with industry standards, but their stability in securing new business is a concern.
Agency Relationships
SACHI BIOWORKS, INC. does not have any specific agency clients listed, which raises concerns about their dependency patterns. Without a clear client base, there is a risk of over-reliance on a single or a few agencies, which could be problematic if those agencies reduce their spending or shift their focus. The lack of detailed information on agency relationships makes it challenging to assess the extent of their reliance on federal contracts.
Red Flags
- No recent contracts: This suggests a potential slowdown in new business and may indicate challenges in securing future contracts.
- No specific agency clients: This raises concerns about dependency risks and the concentration of their client base.
- Lack of sole-source contracts: While this is positive for transparency, it may indicate a competitive disadvantage in securing new business.
Green Flags
- 100% competitive win rate: This suggests that SACHI BIOWORKS, INC. is competing effectively and maintaining a strong market position.
- No sole-source contracts: This indicates a commitment to fair competition and transparency in the contracting process.
- Specialized services: Their focus on biotechnology and specialized services suggests they are meeting specific federal needs.
Key Contracts
SACHI BIOWORKS, INC. has secured a total of $22.4 million in federal contracts, with an average contract size of $3.2 million. While the company has not won any new contracts recently, their existing contracts cover a range of biotechnology services, including biological research, laboratory testing, and contract research organization (CRO) services. These contracts reveal that SACHI BIOWORKS, INC. is well-positioned to support federal research and development efforts. However, the absence of recent wins and the lack of specific agency clients make it difficult to assess their current role and future prospects. Their focus on competitive bidding and specialized services suggests they are meeting specific federal needs, but their stability in securing new business is a concern.
Frequently Asked Questions
What does SACHI BIOWORKS, INC. do for the federal government?
SACHI BIOWORKS, INC. provides specialized biotechnology services, including biological research, laboratory testing, and contract research organization (CRO) services. Their focus on competitive bidding and specialized services suggests they are meeting specific federal needs in research and development.
How much taxpayer money does SACHI BIOWORKS, INC. receive?
SACHI BIOWORKS, INC. has secured a total of $22.4 million in federal contracts, with an average contract size of $3.2 million. While the company has not won any new contracts recently, their existing contracts cover a range of biotechnology services, indicating a significant investment of taxpayer money.
Is SACHI BIOWORKS, INC. good value for taxpayer money?
SACHI BIOWORKS, INC. provides specialized biotechnology services, which are essential for federal research and development. Their competitive bidding approach suggests they are offering fair and transparent services. However, the absence of recent contracts and the lack of specific agency clients make it difficult to assess their overall value to taxpayers. Their contract sizes are in line with industry standards, but their stability in securing new business is a concern.
How does SACHI BIOWORKS, INC. win its contracts?
SACHI BIOWORKS, INC. focuses on competitive bidding, which suggests they are competing effectively and maintaining a strong market position. Their 100% competitive win rate indicates that they are meeting specific federal needs and are committed to fair competition and transparency in the contracting process.
What agencies use SACHI BIOWORKS, INC. most?
SACHI BIOWORKS, INC. does not have any specific agency clients listed, which raises concerns about their dependency patterns. Without a clear client base, there is a risk of over-reliance on a single or a few agencies, which could be problematic if those agencies reduce their spending or shift their focus.
What are the risks of relying on SACHI BIOWORKS, INC.?
The lack of recent contracts and the absence of specific agency clients make it difficult to assess the company's current role and future prospects. The potential for over-reliance on a single or a few agencies, combined with the absence of sole-source contracts, raises concerns about dependency risks and the concentration of their client base. Their stability in securing new business is a concern, which could impact their ability to continue providing services to the federal government.
How does SACHI BIOWORKS, INC. compare to similar contractors?
SACHI BIOWORKS, INC. appears to be a niche player in the biotechnology sector, focusing on specialized services such as biological research and laboratory testing. Their lack of sole-source contracts and absence of recent wins suggest they are competing effectively but may face challenges in maintaining their market position. Their focus on competitive bidding indicates a strong emphasis on fair competition and transparency in the contracting process, but their stability in securing new business is a concern compared to industry peers.
Recent Federal Contracts
Sachi Bioworks, Inc. has 2 federal contracts on record. Below are the largest awards:
| Contract | Agency | Amount | Type |
|---|---|---|---|
| NASA Awards $3.6M Contract for Space-Based Drug Discovery Using Nanoligomers | National Aeronautics and Space Administration | $3.6M | N/A |
| NASA awards $2.2M R&D contract to Sachi Bioworks for spaceflight immune resea... | National Aeronautics and Space Administration | $2.2M | N/A |